280 filings
Page 3 of 14
SC TO-T
jff1tu7f38j6wfu
1 Dec 22
Third party tender offer statement
6:06am
SC 13D/A
9u15yrol
21 Nov 22
Oyster Point Pharma / New Enterprise Associates 14 ownership change
1:29pm
SC14D9C
foprxd8s1ne1rwy tt
16 Nov 22
Written communication relating to third party tender offer
4:24pm
SC TO-C
vlw9jvrq7sj
14 Nov 22
Information about tender offer
8:09am
8-K
4781a38x18qkpmv5lu63
10 Nov 22
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
4:08pm
SC14D9C
vkgtk
8 Nov 22
Written communication relating to third party tender offer
5:22pm
8-K
4u0lhcnhqkz7k4b
8 Nov 22
Entry into a Material Definitive Agreement
5:20pm
SC TO-C
y0keccwn54 i9m
8 Nov 22
Information about tender offer
6:06am
SC TO-C
xkrgoei3 4louwm6
7 Nov 22
Information about tender offer
5:26pm
SC14D9C
t8v663hc
7 Nov 22
Written communication relating to third party tender offer
5:23pm
SC14D9C
4ng1mc3vvou28b
7 Nov 22
Written communication relating to third party tender offer
10:00am
8-K
lt39 lk50jv9b3
7 Nov 22
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
8:15am
8-K
pvwjaqecvzb 17j
11 Aug 22
Oyster Point Pharma Reports Second Quarter 2022 Financial Results and Recent Business Highlights
4:03pm
SC 13G
gkfts76
18 Jul 22
Oyster Point Pharma / Paradigm Biocapital Advisors ownership change
4:24pm
8-K
d0isvjoofxc8
12 Jul 22
Departure of Directors or Certain Officers
4:45pm
4
ek0fwew68e ekl396xh
8 Jul 22
Oyster Point Pharma / Daniel Lochner ownership change
4:55pm
4
oyiq7k2a
8 Jul 22
Oyster Point Pharma / Jeffrey Nau ownership change
4:54pm
8-K
cjzd7dd hu
28 Jun 22
Oyster Point Pharma Announces Operating Expense Streamlining Plan
5:28pm